
We are a private Australian company that has been involved with Proton Pump Inhibitor formulations for a number of years. One of our formulations was tested against a range of cancer types and found to be significantly active in reducing the viability of cancers.
Research into this area is not supported by the Major Pharmaceutical Companies as most Patents on the Proton Pump Inhibitors have expired . JON Pty. Ltd. however has a number of patent applications for formulations of these Proton Pump Inhibitors.
Most Academic Clinical Researcher rely upon significant levels of funding from the Major Pharmaceutical Companies and have been reluctant to trial compounds not supported by these Major Pharmaceutical companies. There are however a minority of Academic Researcher who have offered generous assistance.
We are currently holding discussions with a number of Cancer specialists as regards future human trials.
We are actively encouraging cancer specialists to consider this approach which is significantly less toxic than current chemotherapies in use.